Thomas DiRaimondo
Technik-/Wissenschafts-/F&E-Leiter bei JANUX THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 30.04.2024
Aktive Positionen von Thomas DiRaimondo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JANUX THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2018 | - |
Karriereverlauf von Thomas DiRaimondo
Ehemalige bekannte Positionen von Thomas DiRaimondo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Gründer | 01.01.2013 | 01.08.2019 |
Ausbildung von Thomas DiRaimondo
| Stanford University | Doctorate Degree |
| University of Michigan | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Founder | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
- Börse
- Insiders
- Thomas DiRaimondo
- Erfahrung
